Sartorius Stedim Biotech (CHIX:DIMP) E10: €4.08 (As of Mar. 2026)


CHIX:DIMP Sartorius Stedim Biotech SA CHIX:DIMP
84 GF Score
Price €169.80
GF Value €207.93
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech E10?

Sartorius Stedim Biotech CHIX:DIMP +4.75% 84 E10 is €4.08 as of Mar. 2026. GuruFocus rates CHIX:DIMP with a GF Score™ of 84/100 and a GF Value™ of €207.93 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.910. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €4.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sartorius Stedim Biotech's average E10 Growth Rate was 3.10% per year. During the past 3 years, the average E10 Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sartorius Stedim Biotech was 2.90% per year. The lowest was 2.90% per year. And the median was 2.90% per year.

As of today (2026-06-25), Sartorius Stedim Biotech's current stock price is €169.80. Sartorius Stedim Biotech's E10 for the quarter that ended in Mar. 2026 was €4.08. Sartorius Stedim Biotech's Shiller PE Ratio of today is 41.62.

During the past 13 years, the highest Shiller PE Ratio of Sartorius Stedim Biotech was 120.93. The lowest was 37.37. And the median was 52.06.


Sartorius Stedim Biotech  (CHIX:DIMp) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sartorius Stedim Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=169.80/4.08
=41.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sartorius Stedim Biotech was 120.93. The lowest was 37.37. And the median was 52.06.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sartorius Stedim Biotech E10 Related Terms


Sartorius Stedim Biotech E10 Historical Data

* Premium members only.

The historical data trend for Sartorius Stedim Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech E10 Chart

Sartorius Stedim Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.72 3.90 3.85 3.96

Sartorius Stedim Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.02 4.00 3.92 3.96 4.08

CHIX:DIMP vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Shiller PE Ratio falls into.


CHIX:DIMP
84GF Score
Sartorius Stedim Biotech SA CHIX:DIMP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius Stedim Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.91/131.2583*131.2583
=0.910

Current CPI (Mar. 2026) = 131.2583.

Sartorius Stedim Biotech Quarterly Data

per share eps CPI Adj_EPS
201506 0.350 100.417 0.457
201512 0.000 99.717 0.000
201606 0.430 100.717 0.560
201612 0.000 101.217 0.000
201706 0.420 102.117 0.540
201709 0.400 102.717 0.511
201712 0.490 102.617 0.627
201803 0.440 102.917 0.561
201806 0.540 104.017 0.681
201809 0.540 104.718 0.677
201812 0.740 104.217 0.932
201903 0.610 104.217 0.768
201906 0.700 105.718 0.869
201909 0.630 106.018 0.780
201912 0.590 105.818 0.732
202003 0.810 105.718 1.006
202006 0.720 106.618 0.886
202009 1.080 105.818 1.340
202012 1.030 105.518 1.281
202103 1.360 107.518 1.660
202106 1.610 108.486 1.948
202109 1.610 109.435 1.931
202112 -0.090 110.384 -0.107
202203 2.930 113.968 3.375
202206 2.330 115.760 2.642
202209 2.180 118.818 2.408
202212 2.070 119.345 2.277
202303 1.210 122.402 1.298
202306 1.440 123.140 1.535
202309 0.370 124.195 0.391
202312 0.350 123.773 0.371
202403 0.580 125.038 0.609
202406 0.500 125.882 0.521
202409 0.260 126.198 0.270
202412 0.470 127.041 0.486
202503 0.880 127.779 0.904
202506 0.690 128.412 0.705
202509 0.660 129.255 0.670
202512 0.490 129.361 0.497
202603 0.910 131.258 0.910

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €4.08 mean?
Sartorius Stedim Biotech (CHIX:DIMP) has a E10 of €4.08 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sartorius Stedim Biotech and its competitors.
Is Sartorius Stedim Biotech's E10 too high?
Sartorius Stedim Biotech's current E10 is €4.08. Overall, Sartorius Stedim Biotech has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's E10 compare to ISRG and BDX?
Sartorius Stedim Biotech's E10 of €4.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sartorius Stedim Biotech and its competitors. Sartorius Stedim Biotech's current E10 is €4.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (CHIX:DIMP) is currently considered Modestly Undervalued. The stock's GF Value™ is €207.93, compared to a current price of €169.80 — trading 18.3% below its estimated fair value. The current E10 is €4.08. Sartorius Stedim Biotech's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sartorius Stedim Biotech (CHIX:DIMP), the current E10 is €4.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (CHIX:DIMP) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of €169.80 is trading 18.3% below its estimated GF Value™ of €207.93. GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.

Key valuation signals for CHIX:DIMP:

  • E10: €4.08
  • GF Value™: €207.93 vs. price of €169.80 (18.3% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the CHIX:DIMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
84GF Score

Get the complete analysis for CHIX:DIMP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€169.80
Price
€207.93
GF Value